From: Socio-economic inequalities in the use of drugs for the treatment of chronic diseases in Italy
Tertiles of deprivation | Incidents (n) | Adherence (%)a | Adherence adjusted for age % | Adherence adjusted for age and DI % | Relative difference between Adherence adjusted for age and adjusted for age and DI | Persistance (%)b | Persistance adjusted for age % | Persistance %2 | Relative difference between Persistance adjusted for age and adjusted for age and DI | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Hypertension | Men (≥ 18 year) | 1 | 152,364 | 58.7 (56,9–60,6) | 57.8 | 57.9 | 0.1% | 53.4 (53,1–53,6) | 54.2 | 54.2 | 0.0% |
2 | 160,629 | 58.4 (56,6–60,2) | 54.6 (54,4–54,8) | ||||||||
3 | 177,145 | 56.5 (54,9–58,3) | 54.4 (54,2–54,7) | ||||||||
Women (≥ 18 year) | 1 | 159,560 | 49.5 (47,9–51,1) | 48.5 | 48.5 | 0.1% | 44.1 (43,9–44,4) | 45.0 | 45.0 | 0.0% | |
2 | 167,975 | 49.2 (47,7–50,8) | 45.5 (45,3–45,7) | ||||||||
3 | 176,907 | 47.0 (45,5–48,5) | 45.4 (45,2–45,6) | ||||||||
Dyslipidemia | Men (≥ 18 year) | 1 | 103,990 | 53.8 (52,8–54,8) | 51.9 | 52.1 | 0.4% | 53.8 (53,5–54,1) | 51.8 | 51.7 | -0.1% |
2 | 112,564 | 52.7 (51,7–53,6) | 52.8 (52,5–53,1) | ||||||||
3 | 137,595 | 50.0 (49,1–50,8) | 49.3 (49,1–49,6) | ||||||||
Women (≥ 18 year) | 1 | 103,113 | 42.3 (41,4–43,2) | 40.5 | 40.8 | 0.6% | 44.2 (43,9–44,5 | 43.4 | 43.4 | 0.1% | |
2 | 114,359 | 41.3 (40,5–42,1) | 44.2 (43,9–44,5) | ||||||||
3 | 146,235 | 38.8 (38,1–39,5) | 42.1 (41,9–42,4) | ||||||||
Osteoporosis | Men (≥ 18 year) | 1 | 5,056 | 72.0 (69,6–74,4) | 67.8 | 67.8 | 0.1% | 49.5 (48,1–50,9) | 43.4 | 43.0 | -0.9% |
2 | 4,969 | 68.2 (65,9–70,5) | 44.5 (43,2–45,9) | ||||||||
3 | 5,212 | 63.6 (61,5–65,8) | 36.6 (35,3–37,9) | ||||||||
Women (≥ 18 year) | 1 | 39,514 | 71.4 (70,0–73,0) | 69.8 | 70.1 | 0.4% | 55.4 (54,9–55,9) | 51.8 | 51.9 | 0.2% | |
2 | 44,308 | 70.7 (69,2–72,1) | 53.0 (52,6–53,5) | ||||||||
3 | 54,808 | 68.2 (66,9–69,7) | 48.3 (47,8–48,7) | ||||||||
Diabetes | Men (≥ 18 year) | 1 | 36,431 | 41.9 (39,9–43,9) | 37.6 | 38.0 | 1.2% | 44.0 (43,5–44,5) | 43.2 | 43.2 | 0.0% |
2 | 43,054 | 37.4 (35,6–39,1) | 42.7 (42,3–43,2) | ||||||||
3 | 54,985 | 35.0 (33,5–36,5) | 43.1 (42,7–43,5) | ||||||||
Women (≥ 18 year) | 1 | 29,196 | 37.1 (35,2–39,2) | 31.6 | 32.2 | 1.8% | 38.3 (37,8–38,9) | 36.8 | 36.8 | 0.0% | |
2 | 39,911 | 31.9 (30,4–33,6) | 36.0 (35,5–36,4) | ||||||||
3 | 50,436 | 28.3 (27,0–29,7) | 36.5 (36,1–37,0) | ||||||||
COPD | Men (≥ 18 year) | 1 | 40,013 | 37.1 (35,8–38,5) | 36.1 | 36.4 | 0.8% | 24.8 (24,4–25,3) | 23.7 | 23.7 | 0.0% |
2 | 46,773 | 37.2 (36,0–38,5) | 25.0 (24,6–25,4) | ||||||||
3 | 67,152 | 34.8 (33,8–35,8) | 22.2 (21,9–22,5) | ||||||||
Women (≥ 18 year) | 1 | 42,549 | 32.1 (30,9–33,3) | 30.5 | 30.7 | 0.7% | 19.9 (19,5–20,3) | 18.0 | 18.0 | -0.2% | |
2 | 52,046 | 31.2 (30,2–32,3) | 18.9 (18,6–19,3) | ||||||||
3 | 70,427 | 29.0 (28,2–29,9) | 16.2 (15,9–16,5) |